MARTIN DANIEL C. (Chief Commercial Officer) sold 3.3% of their position (1.62K shares) of DECIPHERA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $23.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/18/2024ACC: 0000950170-24-005388
Officer· Chief Commercial Officer
Since Sep 2018
-1.62K
Net shares
Net seller
$23.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.62K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.62K
Price / share
$14.47
Trade value
$23.50K
% of position
3.3%
1/16/2024
49.28K→47.66K
Total
Net shares
−1.62K
Net value
-$23.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/16/2024 | S · Sale | −1.62K | $14.47 | $23.50K | 3.3% | 49.28K | 47.66K |
| Total | −1.62K | -$23.50K | ||||||
Derivative Transactions0
No derivative transactions reported